Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Mesoblast regains full rights to stem cell heart failure treatment

Tuesday, June 14, 2016

Mesoblast Ltd on Monday said it had regained full rights to its experimental stem cell therapy for advanced chronic heart failure which is currently in late stage testing from Teva Pharmaceutical Industries While Teva returned its rights to the pote...

Novo diabetes drug cuts heart risks by 13 percent in key trial

Tuesday, June 14, 2016

Novo Nordisks topselling diabetes drug Victoza cut the risk of heart attack stroke and cardiovascular death by percent in a closely watched study that may help boost sales of the injectable medicine Victoza is only the second diabetes drug to show...

India's Dr Reddy's in $350 million deal to buy eight U.S. drugs from Teva, Allergan

Monday, June 13, 2016

Indias secondlargest drugmaker Dr Reddys Laboratories Ltd said it agreed to buy eight generic drugs from Teva Pharmaceutical Industries and Allergan Plc for million in cash to bolster its US business The deal is among Dr Reddys biggest acquisitions...

Zealand Pharma: Positive results from pivotal Phase III clinical trials with iGlarLixi

Monday, June 13, 2016

Zealand Pharma AS Positive results from pivotal Phase III clinical trials with iGlarLixi Type diabetes patients treated with iGlarLixi formerly LixiLan had significantly greater reductions in blood glucose HbAc versus treatment with either lixisena...

Sanofi says LixiLan diabetes drug trials meet targets

Monday, June 13, 2016

Frances Sanofi said on Sunday that two latestage Phase III clinical trials of its LixiLan diabetes drug had met their targets readying it for approval in the United States in August and Europe early next year LixiLan consists of a singleinjection co...

Zealand Pharma and Beta Bionics to collaborate

Saturday, June 11, 2016

Zealand Pharma and Beta Bionics to collaborate on development of firstinclass dualhormonal bionic pancreas system for treatment of people with type diabetes Financial guidance for remains unchanged Synergistic match of Beta Bionics dualhormonal a...

EU wants more transparency on AbbVie's Humira, world's top drug

Saturday, June 11, 2016

Details of clinical trials involving AbbVies rheumatoid arthritis drug Humira the worlds topselling prescription medicine are still being withheld without justification according to the European Unions ombudsman Humira has been at the center of a pr...

U.S. panel backs approval for Merck infectious diarrhea drug

Friday, June 10, 2016

Merck Cos experimental drug to treat the most common cause of hospitalassociated infectious diarrhea warrants approval an advisory panel to the US Food and Drug Administration said on Thursday The panel voted with one abstention that the drug bezl...

Colombia to set new price for Novartis cancer drug: minister

Friday, June 10, 2016

Colombia will set a new price for the Novartis cancer drug imatinib in a bid to cut healthcare costs after price negotiations with the Swiss company broke down the health minister said on Thursday A socalled public interest declaration for imatinib...

Valeant pays $54 million to settle U.S. kickback, fraud claims

Friday, June 10, 2016

Valeant Pharmaceuticals International Inc will pay million to settle civil charges that its Salix unit paid illegal kickbacks to induce doctors to prescribe seven of its products causing the submission of thousands of fraudulent reimbursement claims...